Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Sensitivity of Scar-biopsies for Residual Colorectal Adenocarcinoma After Endoscopic Resection With Uncertain Radicality

NCT02328664 is registered in ClinicalTrials.gov with Dr. Frank ter Borg MD PhD as lead sponsor.

NCT NCT02328664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02328664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Sensitivity of Scar-biopsies for Residual Colorectal Adenocarcinoma After Endoscopic Resection With Uncertain Radicality
Lead sponsor
Dr. Frank ter Borg MD PhD
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2015
Completion date
May 31, 2019
Enrollment
246 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer